FDA clearances, acquisitions & more: 5 device company notes

Here are five updates from spine and orthopedic device companies in the last two weeks:

Advertisement

1. OrthoPediatrics’ subsidiary, Telos Partners, hired Scott Day as senior vice president and general manager.

2. RTI Surgical is splitting its company into independent entities focused on surgical implants and biologics.

3. Abbott’s Proclaim XR spinal cord stimulation system was approved by the FDA for expanded MRI compatibility.

4. NuVasive’s Attrax Putty has been cleared by the FDA for use in interbody fusions of the thoracolumbar spine.

5. Surgalign Holdings acquired equity interest in Interneural Networks, whose artificial intelligence technology identifies possible pathological states.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.